Modulation of Curcuma longa on hepatic steatosis and lipid dysregulation in ob/ob mice
碩士 === 長庚大學 === 中醫學系傳統中醫學 === 100 === Obesity is a risk factor for liver diseases, especially for patients with metabolic syndrome. Of which, early nonalcoholic fatty liver disease (NAFLD) is a key to treatment. Curcuma longa (Curcuma) is known to exert potent anti-inflammatory and anti-oxidant effe...
Main Authors: | Chih Chun Liu, 劉芷君 |
---|---|
Other Authors: | T.Y. Lee |
Format: | Others |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/72626721388938325442 |
Similar Items
-
Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice.
by: Gang Cheng, et al.
Published: (2013-01-01) -
CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice[S]
by: Fatiha Nassir, et al.
Published: (2013-11-01) -
SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob miceResearch in context
by: Yipeng Du, et al.
Published: (2018-10-01) -
The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice.
by: Alexandro J Martagón, et al.
Published: (2015-01-01) -
Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2−/−) or obese (ob/ob) mice
by: Anil K. Agarwal, et al.
Published: (2016-04-01)